
Opinion|Videos|September 13, 2024
Closing Thoughts From The Panel On Pneumococcal Vaccination
The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Unexpected Benefits, Unexpected Limits: The Changing Landscape of GLP-1 Research
2
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
3
Phase 3 MajesTEC-9 Trial Shows Survival Benefit With Teclistamab in Multiple Myeloma
4
Empowering Patients With Complex Regimens: The Pharmacist’s Role in Managing Polypharmacy
5













































































































































































































